Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Nov;4(6):648–652. doi: 10.1128/cdli.4.6.648-652.1997

Expression cloning and humoral immune response to the nucleocapsid and membrane proteins of equine arteritis virus.

A Kheyar 1, S Martin 1, G St-Laurent 1, P J Timoney 1, W H McCollum 1, D Archambault 1
PMCID: PMC170634  PMID: 9384283

Abstract

To provide a convenient and sensitive method for the detection of equine arteritis virus (EAV)-specific serum antibodies, we developed an immunoblot assay employing the EAV nucleocapsid (N) and membrane (M) proteins expressed in a procaryotic expression vector (pMAL-c2) for the production of recombinant maltose-binding (MBP) fusion proteins (MBP-N and MBP-M). The antigenic reactivity of the recombinant fusion proteins and their Xa factor cleavage EAV products was confirmed by immunoblot using horse antisera to EAV. Some horse sera, however, showed immune reactivity to the MBP fusion partner protein. Based on a total of 32 horse sera analyzed for the presence of EAV antibodies by immunoblot, using the MBP-N or -M fusion proteins and the Xa factor cleavage EAV products, and in the serum neutralization test, there was 100% concordance between the assays. Sera from horses experimentally infected with EAV were reactive in the immunoblot test with both the MBP-N and the MBP-M fusion proteins by day 14 after EAV exposure. The reactivity continued to the end of the experiment at day 145 after infection. This immune reactivity correlated with the detection of neutralizing antibodies in the serum samples. Based on these findings, the recombinant N and M proteins might be useful for serodetection of EAV-infected animals.

Full Text

The Full Text of this article is available as a PDF (430.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archambault D., Wang Z. M., Lacal J. C., Gazit A., Yaniv A., Dahlberg J. E., Tronick S. R. Development of an enzyme-linked immunosorbent assay for equine infectious anemia virus detection using recombinant Pr55gag. J Clin Microbiol. 1989 Jun;27(6):1167–1173. doi: 10.1128/jcm.27.6.1167-1173.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRYANS J. T., DOLL E. R., KNAPPENBERGER R. E. An outbreak of abortion caused by the equine arteritis virus. Cornell Vet. 1957 Jan;47(1):69–75. [PubMed] [Google Scholar]
  3. Balasuriya U. B., Maclachlan N. J., De Vries A. A., Rossitto P. V., Rottier P. J. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Virology. 1995 Mar 10;207(2):518–527. doi: 10.1006/viro.1995.1112. [DOI] [PubMed] [Google Scholar]
  4. Balasuriya U. B., Timoney P. J., McCollum W. H., MacLachlan N. J. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology. 1995 Dec 20;214(2):690–697. doi: 10.1006/viro.1995.0087. [DOI] [PubMed] [Google Scholar]
  5. Chirnside E. D., Francis P. M., Mumford J. A. Expression cloning and antigenic analysis of the nucleocapsid protein of equine arteritis virus. Virus Res. 1995 Dec;39(2-3):277–288. doi: 10.1016/0168-1702(95)00098-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chirnside E. D., Francis P. M., de Vries A. A., Sinclair R., Mumford J. A. Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus. J Virol Methods. 1995 Jul;54(1):1–13. doi: 10.1016/0166-0934(95)00020-U. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chirnside E. D., Spaan W. J. Reverse transcription and cDNA amplification by the polymerase chain reaction of equine arteritis virus (EAV). J Virol Methods. 1990 Nov;30(2):133–140. doi: 10.1016/0166-0934(90)90014-7. [DOI] [PubMed] [Google Scholar]
  8. Chirnside E. D., Wearing C. M., Binns M. M., Mumford J. A. Comparison of M and N gene sequences distinguishes variation amongst equine arteritis virus isolates. J Gen Virol. 1994 Jun;75(Pt 6):1491–1497. doi: 10.1099/0022-1317-75-6-1491. [DOI] [PubMed] [Google Scholar]
  9. Chirnside E. D., de Vries A. A., Mumford J. A., Rottier P. J. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J Gen Virol. 1995 Aug;76(Pt 8):1989–1998. doi: 10.1099/0022-1317-76-8-1989. [DOI] [PubMed] [Google Scholar]
  10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  11. Deregt D., de Vries A. A., Raamsman M. J., Elmgren L. D., Rottier P. J. Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization. J Gen Virol. 1994 Sep;75(Pt 9):2439–2444. doi: 10.1099/0022-1317-75-9-2439. [DOI] [PubMed] [Google Scholar]
  12. Fukunaga Y., Matsumura T., Sugiura T., Wada R., Imagawa H., Kanemaru T., Kamada M. Use of the serum neutralisation test for equine viral arteritis with different virus strains. Vet Rec. 1994 May 28;134(22):574–576. doi: 10.1136/vr.134.22.574. [DOI] [PubMed] [Google Scholar]
  13. Glaser A. L., de Vries A. A., Dubovi E. J. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance. J Gen Virol. 1995 Sep;76(Pt 9):2223–2233. doi: 10.1099/0022-1317-76-9-2223. [DOI] [PubMed] [Google Scholar]
  14. Golnik W., Michalska Z., Michalak T. Natural equine viral arteritis in foals. Schweiz Arch Tierheilkd. 1981 Oct;123(10):523–533. [PubMed] [Google Scholar]
  15. Hedges J. F., Balasuriya U. B., Timoney P. J., McCollum W. H., MacLachlan N. J. Genetic variation in open reading frame 2 of field isolates and laboratory strains of equine arteritis virus. Virus Res. 1996 Jun;42(1-2):41–52. doi: 10.1016/0168-1702(96)01294-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lepage N., St-Laurent G., Carman S., Archambault D. Comparison of nucleic and amino acid sequences and phylogenetic analysis of the Gs protein of various equine arteritis virus isolates. Virus Genes. 1996;13(1):87–91. doi: 10.1007/BF00576983. [DOI] [PubMed] [Google Scholar]
  17. Murphy T. W., McCollum W. H., Timoney P. J., Klingeborn B. W., Hyllseth B., Golnik W., Erasmus B. Genomic variability among globally distributed isolates of equine arteritis virus. Vet Microbiol. 1992 Sep;32(2):101–115. doi: 10.1016/0378-1135(92)90099-f. [DOI] [PubMed] [Google Scholar]
  18. Revision of the taxonomy of the Coronavirus, Torovirus and Arterivirus genera. Arch Virol. 1994;135(1-2):227–237. doi: 10.1007/BF01309782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sekiguchi K., Sugita S., Fukunaga Y., Kondo T., Wada R., Kamada M., Yamaguchi S. Detection of equine arteritis virus (EAV) by polymerase chain reaction (PCR) and differentiation of EAV strains by restriction enzyme analysis of PCR products. Arch Virol. 1995;140(8):1483–1491. doi: 10.1007/BF01322675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snijder E. J., Wassenaar A. L., Spaan W. J. Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J Virol. 1994 Sep;68(9):5755–5764. doi: 10.1128/jvi.68.9.5755-5764.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. St-Laurent G., Lepage N., Carman S., Archambault D. Genetic and amino acid analysis of the GL protein of Canadian, American and European equine arteritis virus isolates. Can J Vet Res. 1997 Jan;61(1):72–76. [PMC free article] [PubMed] [Google Scholar]
  23. St-Laurent G., Morin G., Archambault D. Detection of equine arteritis virus following amplification of structural and nonstructural viral genes by reverse transcription-PCR. J Clin Microbiol. 1994 Mar;32(3):658–665. doi: 10.1128/jcm.32.3.658-665.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Timoney P. J., McCollum W. H. Equine viral arteritis. Vet Clin North Am Equine Pract. 1993 Aug;9(2):295–309. doi: 10.1016/S0749-0739(17)30397-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Timoney P. J., McCollum W. H., Roberts A. W., Murphy T. W. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci. 1986 Sep;41(2):279–280. [PubMed] [Google Scholar]
  26. de Vries A. A., Chirnside E. D., Horzinek M. C., Rottier P. J. Structural proteins of equine arteritis virus. J Virol. 1992 Nov;66(11):6294–6303. doi: 10.1128/jvi.66.11.6294-6303.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. de Vries A. A., Raamsman M. J., van Dijk H. A., Horzinek M. C., Rottier P. J. The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J Virol. 1995 Jun;69(6):3441–3448. doi: 10.1128/jvi.69.6.3441-3448.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. den Boon J. A., Snijder E. J., Chirnside E. D., de Vries A. A., Horzinek M. C., Spaan W. J. Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J Virol. 1991 Jun;65(6):2910–2920. doi: 10.1128/jvi.65.6.2910-2920.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Berlo M. F., Rottier P. J., Spaan W. J., Horzinek M. C. Equine arteritis virus-induced polypeptide synthesis. J Gen Virol. 1986 Aug;67(Pt 8):1543–1549. doi: 10.1099/0022-1317-67-8-1543. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES